Form 4 for ARMP Armata Pharmaceuticals, Inc.
Accepted 2022-04-01 00:00:00 ET · period of report 2022-03-31 · accession 0001567619-22-007861 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DI | 2022-04-01 | 2022-03-31 | ARMP | Innoviva, Inc. | Dir, 10% | P - Purchase | $5.00 | +5.39M | 16.37M | +49% | +$26.93M |
| DI | 2022-04-01 | 2022-03-31 | ARMP | Innoviva, Inc. | Dir, 10% | P - Purchase | — | 0 | 2.69M | New | — |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-03-31 | P | A | 5,385,208 | $5.00 | 16,365,969 | I See footnotes | — | — | (F1) See Exhibit 99.1 (F2) See Exhibit 99.1 |
| 2 | Derivative | Warrants to Purchase Common Stock | 2022-03-31 | P | A | 0 | $5.00 | 2,692,604 | I See footnotes | $5.00 · 2022-03-31 to 2027-03-31 | 2,692,604 Common Stock | (F1) See Exhibit 99.1 (F2) See Exhibit 99.1 |